Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis
- PMID: 22941884
- PMCID: PMC4241262
- DOI: 10.1183/09059180.00009311
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis
Abstract
The primary function of the lymphatic system is absorbing and transporting macromolecules and immune cells to the general circulation, thereby regulating fluid, nutrient absorption and immune cell trafficking. Lymphangiogenesis plays an important role in tissue inflammation and tumour cell dissemination. Lymphatic involvement is seen in lymphangioleiomyomatosis (LAM) and idiopathic pulmonary fibrosis (IPF). LAM, a disease primarily affecting females, involves the lung (cystic destruction), kidney (angiomyolipoma) and axial lymphatics (adenopathy and lymphangioleiomyoma). LAM occurs sporadically or in association with tuberous sclerosis complex (TSC). Cystic lung destruction results from proliferation of LAM cells, which are abnormal smooth muscle-like cells with mutations in the TSC1 or TSC2 gene. Lymphatic abnormalities arise from infiltration of LAM cells into the lymphatic wall, leading to damage or obstruction of lymphatic vessels. Benign appearing LAM cells possess metastatic properties and are found in the blood and other body fluids. IPF is a progressive lung disease resulting from fibroblast proliferation and collagen deposition. Lymphangiogenesis is associated with pulmonary destruction and disease severity. A macrophage subset isolated from IPF bronchoalveolar lavage fluid (BALF) express lymphatic endothelial cell markers in vitro, in contrast to the same macrophage subset from normal BALF. Herein, we review lymphatic involvement in LAM and IPF.
Conflict of interest statement
None declared.
Figures
Comment in
-
Global effort against rare and orphan diseases.Eur Respir Rev. 2012 Sep 1;21(125):171-2. doi: 10.1183/09059180.00004112. Eur Respir Rev. 2012. PMID: 22941880 Free PMC article. No abstract available.
References
-
- Kitaichi M, Nishimura K, Itoh H, et al. . Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151: 527–533. - PubMed
-
- Chu S, Horiba K, Usuki J, et al. . Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115: 1041–1052. - PubMed
-
- Urban T, Lazor R, Lacronique J, et al. . Pulmonary lymphangioleiomyomatosis: a study of 69 patients. Medicine 1999; 78: 321–337. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources